BIOPHARMA RELIES ON SINGLE USE SUPPORT TECHNOLOGIES FOR CORONA VACCINE DEVELOPMENT

Amidst the spread of the novel coronavirus COVID-19, the biopharmaceutical industry worldwide is researching for vaccines against the virus. The Tyrolean start-up Single Use Support GmbH is also involved: a biotech company from the USA relies on the technologies of Single Use Support during the clinical phases of vaccine development against SARS-CoV-2 virus. The products used for this purpose, RoSS® and RoSS.KSET, ensure safe transport and efficient storage of the high-quality active ingredients.